Phase II trial of talactoferrin in patients with treatment-refractory non-small cell lung cancer.
Phase of Trial: Phase II
Latest Information Update: 13 Oct 2011
At a glance
- Drugs Talactoferrin alfa (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 13 Oct 2011 Status changed from active, no longer recruiting to completed.
- 09 Jun 2011 Results were presented at the 47th Annual Meeting of the American Society of Oncology (ASCO-2011).
- 07 Jun 2011 Results of subgroup analyses were presented at the 47th Annual Meeting of the American Society of Oncology (ASCO-2011).
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History